Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Federal Trade Commission
Medtronic
McKinsey
Chinese Patent Office
QuintilesIMS
Chubb
Dow

Generated: April 25, 2018

DrugPatentWatch Database Preview

VENTOLIN ROTACAPS Drug Profile

« Back to Dashboard

When do Ventolin Rotacaps patents expire, and what generic alternatives are available?

Ventolin Rotacaps is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in VENTOLIN ROTACAPS is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
Drug patent expirations by year for VENTOLIN ROTACAPS
Synonyms for VENTOLIN ROTACAPS
.alpha.1-[(tert-Butylamino)methyl]-4-hydroxy-m-xylene-.alpha.,.alpha.'-diol sulfate (2:1) salt
(+-)-Salbutamol sulfate
(C13H21NO3)2.H2SO4
022S709
1-(4-Hydroxy-3-hydroxymethylphenyl)-2-(tert-butylamino)ethanol sulfate
1, .alpha.1-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-, sulfate (2:1) (salt)
1, .alpha.1-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-, sulfate (2:1) salt
1,3-Benzenedimethanol, alpha(sup 1)-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, sulfate (2:1) (salt)
1,3-Benzenedimethanol, alpha(sup 1)-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-,sulfate (2:1) (salt)
1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, sulfate (2:1) (salt)
2-(tert-Butylamino)-1-(4-hydroxy-3-hydroxymethylphenyl)ethanol Hemisulfate
2200AH
34245-12-0
36519-31-0
39971-61-4
4-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol hemisulfate
4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol sulfate
4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol; sulfuric acid
4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol;sulfuric acid
5-[2-(tert-Butylamino)-1-hydroxyethyl]-2-hydroxybenzyl Alcohol Hemisulfate
51022-70-9
AB0013333
AB1009413
AC-6369
AC1L22LX
AccuNeb
Accuneb (TN)
Accuvent
Aerotec
AH-3365
AK-51732
AK158331
AKOS015951296
AKOS015994719
Albuterol hemisulfate
ALBUTEROL SULFATE
Albuterol sulfate (USP)
Albuterol sulfate [USAN:USP]
Albuterol sulfate [USAN]
Albuterol sulfate, pharmaceutical secondary standard; traceable to USP, PhEur and BP
Albuterol sulfate, United States Pharmacopeia (USP) Reference Standard
Albuterol Sulfate,(S)
Albuterol sulfate(1:x)
Albuterol sulfate(2:1)
Aloprol
alpha-([t-Butylamino]methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol
alpha-[(tert-Butylamino)methyl]-4-hydroxy-1,3-benzenedimethanol sulfate
alpha(sup 1)-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol sulfate (2:1) (salt)
Amocasin
API0004123
Asmaven sulfate
Asthavent
AX8292143
BCP0726000244
BG0312
Bis((tert-butyl)(beta,3,4-trihydroxyphenethyl)ammonium) sulphate
bis(salbutamol); sulfuric acid
Broncho Inhalat
Bronchospray
Broncodil
Buventol Easyhaler
C13H21NO3??1/2H2SO4
C13H21NO3.H2O4S
CA0122
CCG-100775
CCG-222402
CHEBI:2550
CHEMBL1201026
CHEMBL1441059
CPD000058513
CTK4J3501
D00683
Dipulmin
dl-Salbutamol sulfate
Eae -Ae
EINECS 256-916-8
Emican
Epaq
EU-0101098
Fartolin
FT-0650809
H886
HMS2051A09
HMS3263K18
HMS3266D17
HMS3393A09
Huma-Salmol
Inspiryl
J10322
K-9412
KS-00000RSS
KS-5056
KSC593K0D
Loftan
LP01098
LS-162604
LS-29862
MFCD00055200
MLS000758199
MLS001423971
MolPort-003-933-916
MolPort-005-933-644
NC00025
NCGC00094370-01
NCGC00261783-01
NSC 289928
NSC-289928
NSC289928
OR076774
OVICLFZZVQVVFT-UHFFFAOYSA-N
Pediavent
Proair HFA
Proair Respiclick
Proventil Repetabs
Proventil Repetabs, Solution, Syrup, and Tablets
Proventil-HFA
Pulvinal salbutamol
S 5013
S0531
s2507
Salbutamol Diskus
Salbutamol Easyhaler
Salbutamol hemisulfate
Salbutamol hemisulfate salt
Salbutamol hemisulfate salt, >=98%
Salbutamol hemisulfate salt, VETRANAL(TM), analytical standard
Salbutamol hemisulphate
Salbutamol sulfate
Salbutamol sulfate - Albuterol
Salbutamol sulfate (Albuterol)
Salbutamol sulfate (JP17)
Salbutamol sulfate for system suitability, European Pharmacopoeia (EP) Reference Standard
Salbutamol sulfate, 99% 1g
Salbutamol sulfate, European Pharmacopoeia (EP) Reference Standard
Salbutamol sulfate(Albuterol)
salbutamol sulphate (albuterol sulphate)
Salbutamol Sulphate (Albuterol Sulphate) 1.0 mg/ml in Methanol (as free base)
salbutamol; sulfuric acid
SAM001246971
SC-18559
Sch 13949W sulfate
SCH-13949W
SCH-13949W Sulfate
SCHEMBL33279
SCHEMBL33280
SMR000058513
TBS-7
TL8003382
Tox21_501098
TQ-1016
Venetlin
Ventolin
Ventolin (TN)
Ventolin easy-breathe
Ventolin HFA
Ventolin Nebules
Ventorlin
Volare
VoSpire ER

US Patents and Regulatory Information for VENTOLIN ROTACAPS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline VENTOLIN ROTACAPS albuterol sulfate CAPSULE;INHALATION 019489-001 May 4, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for VENTOLIN ROTACAPS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline VENTOLIN ROTACAPS albuterol sulfate CAPSULE;INHALATION 019489-001 May 4, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline VENTOLIN ROTACAPS albuterol sulfate CAPSULE;INHALATION 019489-001 May 4, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Fuji
Baxter
Daiichi Sankyo
Citi
QuintilesIMS
Cerilliant
Fish and Richardson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.